In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus

Hepatitis delta virus (HDV) can dramatically worsen liver disease in patients coinfected with hepatitis B virus (HBV). No effective medical therapy exists for HDV. The HDV envelope requires HBV surface antigen proteins provided by HBV. Once inside a cell, however, HDV can replicate its genome in the...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Bordier, Bruno B., Ohkanda, Junko, Liu, Ping, Lee, So-Young, Salazar, F.H., Marion, Patricia L., Ohashi, Kazuo, Meuse, Leonard, Kay, Mark A., Casey, John L., Sebti, Saïd M., Hamilton, Andrew D., Glenn, Jeffrey S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 2003
Assuntos:	Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166292/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12897208/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI17704
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!